A detailed history of Aqr Capital Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 618,579 shares of ARDX stock, worth $3.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
618,579
Previous 416,353 48.57%
Holding current value
$3.15 Million
Previous $3.09 Million 38.15%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.28 - $7.57 $1.07 Million - $1.53 Million
202,226 Added 48.57%
618,579 $4.26 Million
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $1.45 Million - $2.3 Million
246,819 Added 145.59%
416,353 $3.09 Million
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $491,356 - $791,043
81,216 Added 91.96%
169,534 $1.24 Million
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $86,892 - $175,369
26,411 Added 42.66%
88,318 $547,000
Q3 2023

Nov 14, 2023

SELL
$3.3 - $4.83 $21,334 - $31,225
-6,465 Reduced 9.46%
61,907 $252,000
Q2 2023

Aug 14, 2023

BUY
$3.23 - $4.95 $220,841 - $338,441
68,372 New
68,372 $231,000
Q2 2022

Aug 15, 2022

BUY
$0.51 - $1.17 $10,263 - $23,546
20,125 New
20,125 $12,000
Q1 2021

May 17, 2021

SELL
$6.1 - $7.69 $264,020 - $332,838
-43,282 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$5.05 - $7.1 $646,859 - $909,446
-128,091 Reduced 74.74%
43,282 $280,000
Q3 2020

Nov 16, 2020

SELL
$5.25 - $7.08 $395,073 - $532,784
-75,252 Reduced 30.51%
171,373 $900,000
Q2 2020

Aug 17, 2020

BUY
$5.37 - $8.11 $26,323 - $39,755
4,902 Added 2.03%
246,625 $1.71 Million
Q1 2020

May 15, 2020

BUY
$4.35 - $8.79 $887,721 - $1.79 Million
204,074 Added 542.04%
241,723 $1.37 Million
Q4 2019

Feb 14, 2020

BUY
$4.23 - $8.29 $159,255 - $312,110
37,649 New
37,649 $283,000
Q2 2019

Aug 14, 2019

SELL
$2.49 - $3.73 $87,339 - $130,833
-35,076 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$1.88 - $3.35 $197,313 - $351,595
-104,954 Reduced 74.95%
35,076 $98,000
Q4 2018

Feb 14, 2019

BUY
$1.66 - $4.16 $87,370 - $218,953
52,633 Added 60.22%
140,030 $251,000
Q3 2018

Nov 15, 2018

BUY
$3.75 - $4.65 $282,903 - $350,800
75,441 Added 630.99%
87,397 $380,000
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.8 $44,237 - $69,344
11,956 New
11,956 $44,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $787M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.